These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6034068)

  • 1. 6-glycine-8-phenyllactic acid bradykinin. Its synthesis, biological activity, and splitting by kininase (carboxypeptidase N).
    Ravdel GA; Filatova MP; Shchukina LA; Paskhina TS; Surovikina MS; Trapeznikova SS; Egorova TP
    J Med Chem; 1967 Mar; 10(2):242-6. PubMed ID: 6034068
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the biological properties of some fibrinogen degradation products (FDP)].
    Malofiejew M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968; 23():1-65. PubMed ID: 4310706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phe8 psi(CH2-NH)Arg9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II.
    Drapeau G; Rhaleb NE; Dion S; Jukic D; Regoli D
    Eur J Pharmacol; 1988 Oct; 155(1-2):193-5. PubMed ID: 2907489
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cleavage of depsipeptide analogs of bradykinin by kininase (carboxypeptidase N) from human and rabbit serum].
    Paskhina TS; Trapeznikova SS
    Biokhimiia; 1967 May; 32(3):527-33. PubMed ID: 5599803
    [No Abstract]   [Full Text] [Related]  

  • 5. Bradykinin potentiating factor.
    Greene LJ; Ferreira SH; Stewart JM
    Chest; 1971 May; 59():Suppl:9S-10S. PubMed ID: 4325034
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and biological studies of novel bradykinin analogues.
    Felix AM; Jimenez MH; Vergona R; Cohen MR
    Int J Pept Protein Res; 1973; 5(4):201-6. PubMed ID: 4759567
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological data on phyllokinin (bradykinyl-isoleucyl-tyrosine o-sulphate) and bradykinyl-isoleucyl-tyrosine.
    Anastasi A; Bertaccini G; Erspamer V
    Br J Pharmacol Chemother; 1966 Sep; 27(3):479-85. PubMed ID: 5970899
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on leukokinins. 3. Pharmacological activities of leukokinins M and PMN.
    Freer R; Chang J; Greenbaum LM
    Biochem Pharmacol; 1972 Dec; 21(23):3107-10. PubMed ID: 4675450
    [No Abstract]   [Full Text] [Related]  

  • 9. [(Patho-)physiology and pharmacology of bradykinin and other plasma kinins. II].
    Ufkes JG; van der Meer C
    Ned Tijdschr Geneeskd; 1976 Jan; 120(4):147-52. PubMed ID: 942763
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic analogue of bradykinin possessing selective and prolonged biological activity.
    Chipens GI; Mutulis FK; Katayev BS; Klusha VE; Misina IP; Myshlyiakova NV
    Int J Pept Protein Res; 1981 Sep; 18(3):302-11. PubMed ID: 7341523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance and prospects of the knowledge of bradykinin in dermatology].
    Musumeci V
    G Ital Dermatol Minerva Dermatol; 1966; 107(5):1019-28. PubMed ID: 6014637
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative pharmacological actions of bradykinin and related kinins of larger molecular weights.
    Reis ML; Okino L; Rocha e Silva M
    Biochem Pharmacol; 1971 Nov; 20(11):2935-46. PubMed ID: 5132102
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis and biological action of bradykinin-like undeca-, dodeca- and tridecapeptides].
    Schröder E
    Experientia; 1965 May; 21(5):271-3. PubMed ID: 5841260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of bradkinin-potentiating snake venom peptides and C-terminal pentapeptide fragment of bradkinin on carboxypeptidase N and kiniase activities of human blood serum].
    Paskhina TS; Traleznikova SS; Egorovoa TL; Morozova NA
    Biokhimiia; 1975; 40(4):844-53. PubMed ID: 173428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus.
    Erspaemer V; Anastasi A; Bertaccini G; Cei JM
    Experientia; 1964 Sep; 20(9):489-90. PubMed ID: 5857249
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of bradykinin and some of its fragments on smooth muscles and chemotaxis.
    Roch-Arveiller M; Caranikas S; Regoli D; Giroud JP
    Eur J Pharmacol; 1983 Mar; 88(1):99-103. PubMed ID: 6133767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive action of bradykinin and related kinins of larger molecular weights by the intraventricular route.
    Ribeiro SA; Silva MR
    Br J Pharmacol; 1973 Mar; 47(3):517-28. PubMed ID: 4730829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kininase and anti-inflammatory activities of acid carboxypeptidase from Penicillium janthinellum.
    Yokoyama S; Oobayashi A; Tanabe O; Ohata K; Shibata Y
    Experientia; 1975 Oct; 31(10):1122-4. PubMed ID: 1204716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension].
    Karpitskiĭ VV; Gomazkov OA
    Biull Eksp Biol Med; 1982 Jan; 93(1):24-6. PubMed ID: 6279206
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on dysbarism: 3. A smooth muscle-acting factor (SMAF) in mouse lungs and its increase in decompression sickness.
    Chryssanthou C; Teichner F; Goldstein G; Kalberer J; Antopol W
    Aerosp Med; 1970 Jan; 41(1):43-8. PubMed ID: 5443047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.